Author: Tom Mirga

Express Scripts Defends 340B Claims ID Requirement

In Other Industry, Trade AssociationApril 8, 202123 Views

Pharmacy benefits manager Express Scripts (ESI) told a hospital group and an HIV/AIDS clinic in recent days that it has “already granted numerous pharmacies extensions” to its controversial new 340B claims identification requirement that went into effect March 1. …

340B Entities Won’t Share in BMS’s $75 Million Medicaid Drug Pricing Settlement

In Federal, JudicialApril 8, 20213 Views

Tom Mirga

340B covered entities were not included in Bristol-Myers Squibb’s $75 million settlement last week of a whistleblower’s claims that BMS “falsely reported improperly reduced average manufacturer prices” (AMPs) on multiple drugs from October 2007 through March 2016.

…

340B Sales Grew 18% from 2019 to 2020, Drug Industry Consulting Firm Says

In Pharma Industry, Research/ReportsApril 8, 202111 Views

Tom Mirga

Drug industry consulting and contract research firm IQVIA reports that prescription drug sales at 340B-discounted prices grew 18.1% year-on-year from 2019 to 2020.

Please Login or Become a Paid Subscriber to View this Content

…

340B Groups Ask Express Scripts to Drop Claims Submission and ID Requirement

In Other Industry, Trade AssociationApril 6, 20216 Views

Tom Mirga

Groups representing 340B health care providers have asked pharmacy benefit manager Express Scripts (ESI) to stop making 340B providers and their contract pharmacies retrospectively submit and flag 340B claims in a way that has never been done before, and that …

340B Hospitals More Likely to Make Medicine More Accessible, Study Finds

In Research/ReportsApril 6, 20215 Views

Tom Mirga

340B hospitals provide “a significantly higher average number” of medication access (MA) services—such as free or discounted drugs or free delivery—than comparably sized non-340B hospitals, a new academic study shows.

Please Login or Become a Paid

…

Study in Health Affairs Could Reignite Debate Over Some 340B Hospitals Charity Care

In Research/ReportsApril 6, 20212 Views

Tom Mirga

A study published online by Health Affairs yesterday focused on nonprofit hospitals’ provision of charity care could renew drug manufacturers’ calls for more control over those hospitals’ participation in the 340B program.

Please Login or Become

…

AHA Warns MedPAC its Recommendations Would Harm 340B Hospitals

In Federal, Legislative, RegulatoryApril 6, 20215 Views

Tom Mirga

Congressional Medicare policy advisers on Friday unanimously endorsed Medicare Part B drug reimbursement changes that hospitals say would amplify the effect of Part B drug payment cuts for 340B hospitals in place since 2018.

Please Login

…

HHS’s Latest Regulatory Agenda Is Silent on 340B, but Program Rulemaking Is Possible

In Federal, RegulatoryApril 1, 20215 Views

Tom Mirga

The U.S. Health and Human Services Department (HHS) yesterday released the spring edition of its twice-annual public inventory of forthcoming regulatory actions. Although it was silent about the 340B program, 340B stakeholders shouldn’t breathe a sigh of relief yet. …

AHA Asks Becerra to Waive a 340B Hospital Eligibility Requirement During COVID-19 Emergency

In Federal, RegulatoryApril 1, 20212 Views

Tom Mirga

The American Hospital Association (AHA) yesterday asked U.S. Health and Human Services (HHS) Secretary Xavier Becerra to temporarily waive 340B program eligibility criteria for hospitals at risk of losing their 340B eligibility due to changes in payer mix caused by …

For-Profit Hospitals Back Medicare’s 340B Hospital Cuts in Legal Brief, Study, and Blog

In Federal, JudicialApril 1, 20212 Views

Tom Mirga

The association for U.S. for-profit hospitals yesterday made its strongest pitch yet to preserve the nearly 30 percent cut in what Medicare pays many public and private nonprofit hospitals for physician-administered, 340B-purchased drugs.

Please Login or

…